publication . Article . 2008

Determining the susceptibility to first-line drugs in M. tuberculosis isolates using the mycobacteria growth indicator tube method

Claudia Rocío Sierra Parada; Édgar Alberto Sánchez Morales; Sandra Consuelo Henao Riveros; Alfredo Saavedra Rodríguez;
Open Access Spanish
  • Published: 01 Mar 2008
  • Publisher: Universidad Nacional de Colombia
Abstract
Antecedentes. La aparición de aislamientos de Mycobacterium tuberculosis resistentes a los medicamentos ha hecho que se busquen métodos más rápidos y confiables para la determinación de la susceptibilidad a las drogas antituberculosas. Objetivo. Determinación de la susceptibilidad a drogas antituberculosas de primera línea en aislamientos de M. tuberculosis utilizando el método del tubo indicador de crecimiento micobacteriano (MGIT). Material y métodos. Se estudiaron 49 aislamientos de M. tuberculosis procedentes del laboratorio de micobacteriología del departamento de Microbiología de la Universidad Nacional de Colombia. Se evaluó y comparó el método MGIT para ...
Read more
Subjects
free text keywords: tuberculosis, MGIT, resistencia bacteriana a drogas, susceptibilidad, drug resistance, susceptibility, Medicine, R, Medicine (General), R5-920
Related Organizations
Download fromView all 2 versions
Scientific Electronic Library Online - Colombia
Article . 2008
Provider: Scientific Electronic Library Online - Colombia
Revista de la Facultad de Medicina
Article . 2008
Provider: DOAJ-Articles
27 references, page 1 of 2

1. Daniel TM. The history of tuberculosis. Respiratory Medicine (2006), doi:10.1016/j.rmed.2006.08.006.

2. Cave AJE. The evidence for the incidence of tuberculosis in ancient Egypt. Br. J Tubercl. 1939;33:142 -52.

3. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO report 2006. Geneva, World Health Organization. (WHO/HTM/TB2006.362).

4. Espinal MA, The global situation of MDR-TB. Tuberculosis. 2003;83:44-51. [OpenAIRE]

5. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, MMWR Morb Mortal Wkly Rep. 2006;55:301-305.

6. Migliori GB, Loddenkemper R, Blasi F, Raviglione MC. 125 years after Robert Koch´s discovery of the tubercle bacillus: the new XDR-TB threat. Is «science» enough to tackle the epidemic? Eur Respir. J. 2007;29:423-427. [OpenAIRE]

7. Raviglione MC, Espinal MA. Towards optimization of surveillance resistence to antituberculosis drug resistance. Eurosurveilance Monthly 2000;10:103-104 [OpenAIRE]

8. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reiniero A. Global trends in resistance to antituberculosis drugs. N Engl J Med. 2001;344: 1294-1303. [OpenAIRE]

9. León CI, Sierra CR, Naranjo ON, Garzón MC, Guerrero MI. Segundo estudio nacional de resistencia primaria del Mycobacterium tuberculosis a las drogas.INFECTIO.2002;6:83.

10. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva, World Health Organization (WHO/HTM/TB2006.361

11. Canetti G, Froman F, Grosset J, Hauduroy P, Langerova M, Meisser G, Mitchison DA, Sula L. Mycobacteria: Laboratory methods for testing drug sensitivity and resistance. Bull WHO. 1963;29;565-578. [OpenAIRE]

12. Palomino JC. Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis. Curr Opin Pulm Med 2006;12:172-178. [OpenAIRE]

13. Robledo JR, Mejia GI. Actualidad en el diagnóstico de la tuberculosis por el laboratorio. INFECTIO. 2001;5:251-258.

14. Becton Dickinson Microbiology Systems. BACTEC MGIT 960 System product and procedure manual. USA, 2001.

15. Echeverry J, Ardila E. Pruebas diagnósticas y proceso diagnóstico. En: Estrategias de Investigación en medicina clínica. Bogotá: Editorial Manual Moderno. 2001.

27 references, page 1 of 2
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue